PLSE - CIK 0001625101
The table below shows Pulse Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $68.32M | $95.21M | $106.35M | $119.28M | $79.03M | $26.20M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $157.00K | $15.00K | - | - | - | - |
| Inventory | $206.00K | $57.00K | $51.00K | $30.00K | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $71.13M |
| $97.16M |
| $108.16M |
| $120.91M |
| $80.41M |
| $27.24M |
| Property, plant & equipment | $1.02M | $1.05M | $1.11M | $1.06M | $1.22M | $1.31M |
| Goodwill | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M |
| Total assets | $81.62M | $108.77M | $120.25M | $133.38M | $93.05M | $40.43M |
| Accounts payable | $2.76M | $2.98M | $2.74M | $2.37M | $1.73M | $1.64M |
| Total current liabilities | $9.80M | $9.70M | $8.98M | $7.76M | $6.74M | $5.96M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $15.32M | $16.07M | $15.76M | $14.93M | $13.91M | $13.46M |
| Retained earnings | -$481.86M | -$445.85M | -$426.46M | -$407.30M | -$371.12M | -$358.44M |
| Total equity | $66.30M | $92.69M | $104.49M | $118.45M | $79.13M | $26.97M |